The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis
Pease A, Lo C, Earnest A, et al.
Diabetes Technol Ther. 2020;22(5):11-421
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Diabetes and COVID‐19: psychosocial consequences of the COVID‐19 pandemic in people with diabetes in Denmark—what characterizes people with high levels of COVID‐19‐related worries?
Joensen LE, Madsen KP, Holm L, et al.
Diabet Med. Pub. Online 11 May 2020
Leggi
Cost-effectiveness analysis of a hybrid closed-loop system versus multiple daily injections and capillary glucose testing for adults with type 1 diabetes
Pease AJ, Zomer E, Liew D, et al.
Diabetes Technol Ther. Pub. online, 29 April 2020
Leggi
Sodium-glucose cotransporter 2 inhibitors in heart failure: a meta-analysis of randomized clinical trials
Kumar K, Kheiri B, Simpson TF, et al.
Am J Med. 2020;S0002-9343(20)30361-2
Leggi
Risk and adverse outcomes of gestational diabetes in migrants: A population cohort study.
Seghieri G, Cianni GD, Seghieri M, Lacaria E, Corsi E, Lencioni C, Gualdani E, Voller F, Francesconi P
Diabetes Res Clin Pract. 2020;163:108128
Leggi
Top 10 tips for successfully implementing a diabetes telehealth program
Crossen S, Raymond J, Neinstein A
Diabetes Technol Ther. Pub. online 21 April 2020
Leggi
SGLT2 inhibitors and kidney outcomes in the real world
Smith SM
BMJ 2020;369:m1584
Leggi
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak B, Wintzell V, Melbye M, et al.
BMJ 2020;369:m1186
Leggi
Managing new-onset type 1 diabetes during the COVID-19 pandemic: challenges and opportunities
Garg SK, Rodbard D, Hirsch IB, Forlenza GP
Diabetes Technol Ther. Pub. online 17 April 2020
Leggi
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
Ehrmann D, Kulzer B, Roos T, et al.
Lancet Diabet Endocrinol. 2020;8(5):436-46
Leggi